Cargando…
80例晚期NSCLC吉非替尼治疗长于6个月患者的预后因素分析
BACKGROUND AND OBJECTIVE: Some clinical predictors can be used to evaluate the efficacy of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for non-small cell lung cancer (NSCLC), including female, East-Asian, non-smoker, adenocarcinoma, skin rash, etc. The aim of this s...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000485/ https://www.ncbi.nlm.nih.gov/pubmed/21081047 http://dx.doi.org/10.3779/j.issn.1009-3419.2010.11.10 |